Preparation and Characterization of Meloxicam–Myrj-52 Granules Obtained by Melt Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Preparation and Characterization of Meloxicam–Myrj-52 Granules Obtained by Melt Granulation
Various manufacturing techniques can improve a drug's solubility, thus increasing its bioavailability. The authors examined whether melt granulation can enhance drug solubility using meloxicam as the drug substance and myrj-52 as the binder.


Pharmaceutical Technology


7. P.W.S. Hengh, L.W. Chan, and L. Zhu, "Effects of Process Variables and their Interactions on Melt Pelletization in a High Shear Mixer," Stp. Pharm. Sci. 10 (2), 165–172 (2000).

8. R.C. Rowe, P.J. Sheskey, and P.J. Weller, "Polyoxyethylene Stearates," in Handbook of Pharmaceutical Excipients , (Pharmaceutical Press, London, 4th ed., 2000), pp. 284–287.

9. R.L. Jackson and M.D. Jason, "Analgesic-Antipyretic and Anti-Inflammatory Agents and Drugs Employed in the Treatment of Gout," in Goodman & Gilman's The Pharmacological Basis of Therapeutics , J.G. Hardman and L.E. Limbird, Eds. (McGraw-Hill, New York, 2001), pp. 713–714.

10. N.B. Naidu et al., "Physico-Chemical Characterization and Dissolution Properties of Meloxicam–Cyclodextrin Binary Systems," J. Pharm. Biomed. Anal. 35 (1), 75–86 (2004).

11. M.M. Ghorab et al., "Tablet Formulation Containing Meloxicam and -Cyclodextrin: Mechanical Characterization and Bioavailability Evaluation," AAPS PharmSciTech. 5 (4), E59 (2004).

12. N. Seedher and S. Bhatia, "Solubility Enhancement of Cox-2 Inhibitors Using Various Solvent Systems," AAPS PharmSciTech. 4 (3), E1–E6 (2003).

13. R.G. Cantera, M.G. Leza, and C.M. Bachiller, "Solid Phases of Tenoxicam," J. Pharm. Sci. 91 (10), 2240–2251 (2002)

14. Hazi Valizadeh, Ali Nokhodchi, and Nahid Qarakhani, "Physiological Characterisation of Solid Dispersion of Indomethacin with pEG 6000, Myrj-52, Lactose, Sorbitol, Dextrin, and Eudragit E100," Drug Dev. Ind. Pharm. 30 (3), 303–317 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here